US › Healthcare

CapsoVision, Inc. Common Stock (CV)

US · Healthcare · Medical Devices

$6.94-3.21%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$2.8M
Revenue YoY
+0.3%
Net profit
$-7.0M
Profit YoY
-30.8%
EPS
$-0.15
EPS estimate
$-0.13
Net margin
-251.9%

EPS came in at -0.15 against a street estimate of -0.13 — a miss of 15.4%.

Key statistics

Market cap
$328.8M
Forward P/E
0.0
P/B
16.23
Book value
$0.41
EPS (TTM)
$-1.06
52-week high
$15.37
52-week low
$3.43
50-day MA
$6.76
200-day MA
$6.61

Analyst view

with an average price target of $10.00.

Shareholding

Insiders
32.09%
Institutions
8.16%

Largest institutional holders

FundStake
BlackRock Inc2.61%
Vanguard Capital Management, LLC2.05%
Geode Capital Management, LLC0.87%
State Street Corp0.51%
Vanguard Portfolio Management, LLC0.33%
Northern Trust Corp0.30%
Vanguard Fiduciary Trust Co0.18%
XTX Topco Ltd0.13%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for CapsoVision, Inc. Common Stock — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.